This page is part of the FHIR Specification (v0.5.0: DSTU 2 Ballot 2). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
This is the narrative for the resource. See also the XML or JSON format.
Generated Narrative with Details
dateWritten: Mar 11, 2013
status: ACTIVE
Id | Extension | ModifierExtension | Text | AdditionalInstructions | Scheduled[x] | AsNeeded[x] | Site | Route | Method | Dose[x] | Rate | MaxDosePerPeriod |
aerosol 25/250ug/do 120do 2x - 1 dose - daily | Starting Mar 11, 2013, Do 2 per 1days, Until May 11, 2013 | Oral cavity (Details : {SNOMED CT code '74262004' = 'Oral cavity', given as 'Oral cavity'}) | Respiratory tract (Details : {SNOMED CT code '321667001' = 'Respiratory tract', given as 'Respiratory tract'}) | Salmeterol+fluticasone 25/250ug inhaler (Details : {SNOMED CT code '320276009' = 'Salmeterol+fluticasone propionate 25micrograms/250micrograms CFC-free inhaler', given as 'Salmeterol+fluticasone 25/250ug inhaler'}) | 1 PUFF (Details: http://hl7.org/fhir/v3/orderableDrugForm code PUFF = 'Puff') | 2 puffs (Details: SNOMED CT code 415215001 = 'Puff - unit of product usage (qualifier value)')/1 daily (Details: SNOMED CT code 259032004 = 'per day (qualifier value)') |
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.